PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of Lamotrigine ER Tablets to its current portfolio.

Lamotrigine ER Tablets are indicated as adjunctive therapy for primary generalized tonic-clonic (PGTC) seizures and partial- onset seizures with or without secondary generalization in patients aged 13 years and older.

Lamotrigine ER Tablets from Camber are available in 25, 50, 100, 200, 250, and 300 mg strengths in 30 count bottles.